Olfaction Disorders clinical trials
The registry lists 70 studies for Olfaction Disorders across more than 10 countries. 18 are recruiting or about to start. 27 of them are mainly about Olfaction Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-09. Counting its narrower condition Anosmia too: 213 studies, 56 open.
Get an email when these change. Save the Olfaction Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Washington University School of Medicine (7) · Stanford University (3) · Central Hospital, Nancy, France (2) · Peking University Third Hospital (2) · University of North Carolina, Chapel Hill (2) · Menoufia University (2) · Centre Hospitalier Universitaire de Nice (2) · Medical University of South Carolina (2)
What is being tested here
Drugs under test in Olfaction Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6
- Jan 2027Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat · Universitaire Ziekenhuizen KU Leuven
- Mar 2027Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia · Stanford University
- May 2027Olfactory Training in Various Populations · University of Kansas Medical Center
- Jun 2027Olfactory Training on Smell Dysfunction Patients in HK · Pamela Youde Nethersole Eastern Hospital
- Sep 2027Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 · Université du Québec à Trois-Rivières
- Sep 2027Impact of Smell Testing on Health Outcomes · Monell Chemical Senses Center
Who these studies take
Of the 14 Olfaction Disorders studies recruiting now, 7 (50%) set no upper age limit and 5 (36%) stop at 75 or younger. 4 (29%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (21%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (14%) | 2 (14%) |
| 18 | 13 (93%) | 13 (93%) |
| 30 | 13 (93%) | 13 (93%) |
| 40 | 13 (93%) | 13 (93%) |
| 50 | 13 (93%) | 13 (93%) |
| 65 | 12 (86%) | 12 (86%) |
| 75 | 9 (64%) | 9 (64%) |
| 85 | 8 (57%) | 8 (57%) |
Across all 70 studies, recruiting or not: 40% stop at 75 or younger and 26% at 65; 10% take children; 0% are for women only and 0% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Olfaction Disorders studies take
Of 20 interventional studies with no phase under Olfaction Disorders, half reached primary completion within 24 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 24 mo12–43 · 20 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 70. Browse all 70 → or search them.
- Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)RecruitingNCT071494281 country
- Impact of Smell Testing on Health OutcomesRecruitingNCT07222891Phase 21 country
- Sinus Disease in Young Children With Cystic FibrosisRecruitingNCT061916401 country
- Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open LabelRecruitingNCT07689773Phase 21 country
- Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19RecruitingNCT05384561Not applicable1 country
- Olfactory Training in Various PopulationsEnrolling by invitationNCT06115291Not applicable1 country
- Olfactory BiopsiesRecruitingNCT07021040Not applicable1 country
- Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)RecruitingNCT05855369Phase 2/31 country
- Adaptation Strategies for Coping With the Impact of Sensory Alterations on Eating Behavior in Children With Cancer: A Qualitative Study From the Perspective of Children and ParentsNot yet recruitingNCT074900931 country
- The Effectiveness of Steroid Nasal Drops in the Olfactory Cleft Combined With Olfactory Training for Patients With PIODNot yet recruitingNCT07386860Not applicable1 country
- Prospective Registery of Smell/Taste Clinic Ear/Nose/ThroatRecruitingNCT064560081 country
- Olfactory Training on Smell Dysfunction Patients in HKRecruitingNCT05364125Not applicable1 country
- Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of ParosmiaRecruitingNCT06283745Not applicable1 country
- Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced ParosmiaRecruitingNCT06055270Phase 31 country
- The Effect of Olfactory Training in Patients With COVID-19 Induced Olfactory DysfunctionRecruitingNCT05539560Not applicable1 country
- Study of EEG and Nasal Stimulus in Olfactory DisordersNot yet recruitingNCT06589375Not applicable
- GnRH Therapy on Cognition in Down SyndromeRecruitingNCT04390646Phase 2/31 country
- Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT Scan in Pre Septo Rhinoplasty Patients Without Respiratory Mucosa Pathology : Normal Variants or Pathologic Findings ?RecruitingNCT060821931 country
- Effects of Isotretinoin on SmellCompletedNCT07309341Not applicable1 country
- Ultramicronized Palmitoylethanolamide for Smell, Taste in Children With Autism Spectrum Disorder.CompletedNCT07631455Not applicable1 country
- Post-Covid-19 Patients Follow-up StudyCompletedNCT07571382Not applicable1 country
- Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.CompletedNCT07498062Not applicable1 country
- Stellate Ganglion Block for COVID-19-Induced Olfactory DysfunctionCompletedNCT05445921Phase 1/21 country
- Study of Olfactory Disorders in Patients With Cardiac AmyloidosisCompletedNCT04661800Not applicable1 country
- Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of SeverityCompletedNCT04361474Phase 31 country
- The Relationship Between Olfactory and Gustatory Senses, Hedonic Hunger, and Diet Quality After Bariatric SurgeryCompletedNCT072900751 country
- Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 21 country
- Treatment of Olfactory Dysfunction Using Vagus Nerve StimulationActive, not recruitingNCT06817499Not applicable1 country
- Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) InfectionCompletedNCT044669821 country
- Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19CompletedNCT05133596Not applicable1 country
- COVID-19: Post-covid Olfactory Disorders AssessmentCompletedNCT047999771 country
- Efficacy of Gabapentin for Post-Covid-19 Olfactory DysfunctionCompletedNCT05184192Phase 21 country
- Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory DysfunctionActive, not recruitingNCT06204432Phase 21 country
- Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 ParosmiaTerminatedNCT06789952Not applicable1 country
- Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19TerminatedNCT04964414Phase 1/21 country
- The Efficacy of Modified Olfactory Training for Patients With Olfactory DysfunctionStatus unknownNCT06353139Not applicable1 country
- Olfactory and Taste Changes During Fasting Mimicking Diet (FMD)CompletedNCT04529161Not applicable1 country
- Rapid Screening for Olfactory Disorders in Covid-19 InfectionWithdrawnNCT04696601Not applicable1 country
- COVID-19 Anosmia StudyCompletedNCT04495816Phase 21 country
- Smell in Covid-19 and Efficacy of Nasal TheophyllineCompletedNCT04789499Phase 21 country
- Triggers for Post-Viral ParosmiaCompletedNCT048684351 country
- Olfaction Changes in Patients Undergoing Spine SurgeryCompletedNCT041947881 country
- Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19Status unknownNCT050384751 country
- Intranasal Injection of PRP Versus Saline for Treatment of Olfactory DysfunctionCompletedNCT04406584Not applicable1 country
- Lactoferrin for COVID-19-Induced Taste or Smell AbnormalityWithdrawnNCT05760079Not applicable
- "Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.Status unknownNCT05666492Not applicable1 country
- Olfactory Disfunction and Co-ultraPEALutCompletedNCT04853836Phase 41 country
- Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal PolypsTerminatedNCT04104594Not applicable1 country
- Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 PatientsCompletedNCT04526054Not applicable1 country
- Intranasal Insulin for COVID-19-related Smell LossCompletedNCT05461365Phase 31 country